JPS51101953A - - Google Patents

Info

Publication number
JPS51101953A
JPS51101953A JP50131323A JP13132375A JPS51101953A JP S51101953 A JPS51101953 A JP S51101953A JP 50131323 A JP50131323 A JP 50131323A JP 13132375 A JP13132375 A JP 13132375A JP S51101953 A JPS51101953 A JP S51101953A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50131323A
Other languages
Japanese (ja)
Inventor
Joisu Burooton Baabara
Piitaa Riaa Kyatsuton Maikeru
Chaaruzu Jon Koohii Edowaado
Jeimuzu Uooren Piitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of JPS51101953A publication Critical patent/JPS51101953A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP50131323A 1974-11-01 1975-10-31 Pending JPS51101953A (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47417/74A GB1522130A (en) 1974-11-01 1974-11-01 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
JPS51101953A true JPS51101953A (lt) 1976-09-08

Family

ID=10444895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50131323A Pending JPS51101953A (lt) 1974-11-01 1975-10-31

Country Status (14)

Country Link
JP (1) JPS51101953A (lt)
AU (1) AU499135B2 (lt)
BE (1) BE835169A (lt)
CH (1) CH609681A5 (lt)
DE (1) DE2548878A1 (lt)
DK (1) DK492575A (lt)
FI (1) FI753056A (lt)
FR (1) FR2289170A1 (lt)
GB (1) GB1522130A (lt)
HU (1) HU173243B (lt)
LU (1) LU73702A1 (lt)
NL (1) NL7512817A (lt)
SE (1) SE7512206L (lt)
ZA (1) ZA756876B (lt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283721A (en) * 1976-01-01 1977-07-12 Pfizer 111deoxyyomegaapentanolprostaglandins

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486540A (en) * 1993-10-28 1996-01-23 Allergan, Inc. Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283721A (en) * 1976-01-01 1977-07-12 Pfizer 111deoxyyomegaapentanolprostaglandins
JPS581117B2 (ja) * 1976-01-01 1983-01-10 フアイザ−・インコ−ポレ−テツド 11−デオキシ−ω−ペンタノルプロスタグランジン類

Also Published As

Publication number Publication date
FR2289170A1 (fr) 1976-05-28
AU499135B2 (en) 1979-04-05
ZA756876B (en) 1976-10-27
BE835169A (fr) 1976-04-30
CH609681A5 (en) 1979-03-15
DK492575A (da) 1976-05-02
NL7512817A (nl) 1976-05-04
DE2548878A1 (de) 1976-05-13
GB1522130A (en) 1978-08-23
SE7512206L (sv) 1976-05-03
LU73702A1 (lt) 1976-06-11
AU8625175A (en) 1977-05-26
FI753056A (lt) 1976-05-02
HU173243B (hu) 1979-03-28

Similar Documents

Publication Publication Date Title
FR2284317B1 (lt)
FR2293923B1 (lt)
FR2285834B1 (lt)
FR2268610B1 (lt)
FI753056A (lt)
FR2270290A1 (lt)
FR2291143B1 (lt)
FR2268260B1 (lt)
HU168934B (lt)
DK293974A (lt)
CS172046B1 (lt)
CH580873A5 (lt)
BG22732A1 (lt)
BG20159A1 (lt)
BG20443A1 (lt)
DD112472A1 (lt)
BG20650A1 (lt)
CH607144A5 (lt)
CH588826A5 (lt)
CH586862A5 (lt)
CH582083A5 (lt)
BG21353A1 (lt)
CH579901A5 (lt)
CH1357474A4 (lt)
CH1107074A4 (lt)